D.med Healthcare (“D.med”), (Düsseldorf, Germany), is pleased to announce the expansion of its investment in the Brazilian renal market adding another dialysis center, SOS Rim (Porto Velho), to its portfolio.
D.med has been operating in Brazil since acquiring its first dialysis clinic in 2019. With a successful launch that has built a strong community of patients, healthcare professionals, partners and a wealth of innovative projects, the company has decided to continue its expansion into the local renal care market.
“Our current operations in Brazil are a great success story which has motivated us to further strengthen our footprint. The excellent work that has been done by the SOS Rim team headed by Dra Priscilla Rosal and Dra Tatiara Bueno has very much impressed us, and it will be our pleasure to work together with them towards common future goals. We look forward to partnering with public and private stakeholders in the State of Rondônia by providing the high standard of medical services which D.med stands for in Brazil and elsewhere”, said Sven-Axel Krentorz, CEO of D.med.
“We are delighted with this partnership with the D.med group, which with its international dimension and proven expertise in renal care, should help us further improve our quality standards and patient-centered approach”, said Dr. Tatiara Bueno, co-founder of SOS Rim clinic.
“We are proud to concretize this partnership with D.med, which is not only one of the globally successful and reputable dialysis service providers but also an incredible community of motivated and supportive people that we are thrilled to join”, added Dr. Priscilla Rosal, a co-founder of the clinic.
Headquartered in Düsseldorf, Germany, D.med is a privately owned company group operating globally through a network of premises in over 20 countries as a provider of medical services and products with a focus on renal care, diabetes, and other fields of internal medicine.
For more information on D.med, please visit: www.dmed-healthcare.com
International Director of Operations
Chief Investment Officer